Cargando…

Correction: Predictive biomarkers for disease sensitivity in lymphoma – the holy grail for HDAC inhibitors?

Detalles Bibliográficos
Autor principal: Eyre, Toby A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422189/
https://www.ncbi.nlm.nih.gov/pubmed/30899436
http://dx.doi.org/10.18632/oncotarget.26767
_version_ 1783404347519926272
author Eyre, Toby A.
author_facet Eyre, Toby A.
author_sort Eyre, Toby A.
collection PubMed
description
format Online
Article
Text
id pubmed-6422189
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-64221892019-03-21 Correction: Predictive biomarkers for disease sensitivity in lymphoma – the holy grail for HDAC inhibitors? Eyre, Toby A. Oncotarget Correction Impact Journals LLC 2019-02-26 /pmc/articles/PMC6422189/ /pubmed/30899436 http://dx.doi.org/10.18632/oncotarget.26767 Text en Copyright: © 2019 Eyre et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Correction
Eyre, Toby A.
Correction: Predictive biomarkers for disease sensitivity in lymphoma – the holy grail for HDAC inhibitors?
title Correction: Predictive biomarkers for disease sensitivity in lymphoma – the holy grail for HDAC inhibitors?
title_full Correction: Predictive biomarkers for disease sensitivity in lymphoma – the holy grail for HDAC inhibitors?
title_fullStr Correction: Predictive biomarkers for disease sensitivity in lymphoma – the holy grail for HDAC inhibitors?
title_full_unstemmed Correction: Predictive biomarkers for disease sensitivity in lymphoma – the holy grail for HDAC inhibitors?
title_short Correction: Predictive biomarkers for disease sensitivity in lymphoma – the holy grail for HDAC inhibitors?
title_sort correction: predictive biomarkers for disease sensitivity in lymphoma – the holy grail for hdac inhibitors?
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422189/
https://www.ncbi.nlm.nih.gov/pubmed/30899436
http://dx.doi.org/10.18632/oncotarget.26767
work_keys_str_mv AT eyretobya correctionpredictivebiomarkersfordiseasesensitivityinlymphomatheholygrailforhdacinhibitors